Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review

References

• Grossman K, Beasley MB, Braman SS. Hepatoid adenocarcinoma of the lung: review of a rare form of lung cancer. Respir Med. 2016;119:175–179. doi:10.1016/j.rmed.2016.09.003
   PubMed Web of Science ®Google Scholar
• Chen HF, Wang WX, Li XL, et al. Hepatoid adenocarcinoma of the lung with EGFR mutation and the response to tyrosine kinase inhibitors. J Thorac Oncol. 2019;14(10):e217–e219. doi:10.1016/j.jtho.2019.04.032
   PubMed Web of Science ®Google Scholar
• Yang K, Jiang H, Li Q. Primary pulmonary hepatoid adenocarcinoma: a case report and review of the literature. Medicine. 2019;98(14):e15053. doi:10.1097/md.0000000000015053
   PubMed Web of Science ®Google Scholar
• Murakami T, Yao T, Mitomi H, et al. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer. 2016;19(2):498–507. doi:10.1007/s10120-015-0497-9
   PubMed Web of Science ®Google Scholar
• Ishikura H, Scully RE. Hepatoid carcinoma of the ovary. A newly described tumor. Cancer. 1987;60(11):2775–2784. doi:10.1002/1097-0142(19871201)60:11<2775::aid-cncr2820601130>3.0.co;2-s
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Nagakawa T, Mano S, Taguchi K, Aozasa K. Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production. Int J Gynecol Pathol. 1996;15(3):266–269. doi:10.1097/00004347-199607000-00012
   PubMed Web of Science ®Google Scholar
• Hwang JH, Song SH, Kim YH, et al. Primary hepatoid adenocarcinoma of the endometrium with a high alphafetoprotein level. Scott Med J. 2011;56(2):120. doi:10.1258/smj.2011.011100
   PubMedGoogle Scholar
• Friedman P, Lai JP. Liver metastasis of urothelial carcinoma with hepatoid features: an unusual morphological finding. Anticancer Res. 2017;37(2):801–804. doi:10.21873/anticanres.11380
   PubMed Web of Science ®Google Scholar
• Yang C, Sun L, Lai JZ, et al. Primary hepatoid carcinoma of the pancreas: a clinicopathological study of 3 cases with review of additional 31 cases in the literature. Int J Surg Pathol. 2019;27(1):28–42. doi:10.1177/1066896918783468
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun L, Li Z, et al. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features. Gastric Cancer. 2019;22(6):1183–1192. doi:10.1007/s10120-019-00965-5
   PubMed Web of Science ®Google Scholar
• Metzgeroth G, Ströbel P, Baumbusch T, Reiter A, Hastka J. Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity. Onkologie. 2010;33(5):263–269. doi:10.1159/000305717
   PubMedGoogle Scholar
• Pasricha S, Grover S, Kamboj M, et al. Hepatoid adenocarcinoma of lung: a diagnostic challenge - series of six cases with histopathological, predictive molecular and PD.L1 assessment. Indian J Pathol Microbiol. 2021;64(1):128–131. doi:10.4103/ijpm.Ijpm_334_20
   PubMed Web of Science ®Google Scholar
• Chen JX, Lyu LL, Zhu WH, Chen XY, Zheng L. Hepatoid adenocarcinoma of the lung accompanied with multiple systemic metastases. Chin Med J. 2020;134(2):237–238. doi:10.1097/cm9.0000000000000963
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi:10.1136/bmj.b2700
   PubMed Web of Science ®Google Scholar
• Ishikura H, Kanda M, Ito M, Nosaka K, Mizuno K. Hepatoid adenocarcinoma: a distinctive histological subtype of alpha-fetoprotein-producing lung carcinoma. Virchows Arch A Pathol Anat Histopathol. 1990;417(1):73–80. doi:10.1007/bf01600112
   PubMedGoogle Scholar
• Chen L, Han X, Gao Y, et al. Anti-PD-1 therapy achieved disease control after multiline chemotherapy in unresectable KRAS-positive hepatoid lung adenocarcinoma: a case report and literature review. Onco Targets Ther. 2020;13:4359–4364. doi:10.2147/ott.S248226
   PubMed Web of Science ®Google Scholar
• Haninger DM, Kloecker GH, Bousamra IM, Nowacki MR, Slone SP. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature. Mod Pathol. 2014;27(4):535–542. doi:10.1038/modpathol.2013.170
   PubMed Web of Science ®Google Scholar
• Motooka Y, Yoshimoto K, Semba T, et al. Pulmonary hepatoid adenocarcinoma: report of a case. Surg Case Rep. 2016;2(1):1. doi:10.1186/s40792-016-0129-6
   PubMedGoogle Scholar
• Okunaka T, Kato H, Konaka C, Yamamoto H, Furukawa K. Primary lung cancer producing alpha-fetoprotein. Ann Thorac Surg. 1992;53(1):151–152. doi:10.1016/0003-4975(92)90778-3
   PubMed Web of Science ®Google Scholar
• Valentino F, Torchio M, Morbini P, Danova M. Synchronous presentation of hepatoid alpha-fetoprotein-producing lung cancer and colorectal adenocarcinoma. Tumori. 2012;98(5):130e–134e. doi:10.1700/1190.13214
   PubMedGoogle Scholar
• Fornasa F. Soft-tissue localization of hepatoid adenocarcinoma: first case report. Case Rep Oncol. 2010;3(2):212–217. doi:10.1159/000317419
   PubMedGoogle Scholar
• Papatsimpas G, Kamposioras K, Goula K, et al. Hepatoid pancoast tumor. A case report and review of the literature. Lung Cancer. 2012;77(2):239–245. doi:10.1016/j.lungcan.2012.05.102
   PubMed Web of Science ®Google Scholar
• Miyama Y, Fujii T, Murase K, Takaya H, Kondo F. Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma. Autops Case Rep. 2020;10(2):e2020162. doi:10.4322/acr.2020.162
   PubMedGoogle Scholar
• Li J, Qi H, Xu B, et al. Genomic profiles of a patient of pulmonary hepatoid adenocarcinoma with high AFP level: a case report. Front Oncol. 2019;9:1360. doi:10.3389/fonc.2019.01360
   PubMed Web of Science ®Google Scholar
• Arnould L, Drouot F, Fargeot P, et al. Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor. Am J Surg Pathol. 1997;21(9):1113–1118. doi:10.1097/00000478-199709000-00018
   PubMed Web of Science ®Google Scholar
• Hiroshima K, Iyoda A, Toyozaki T, et al. Alpha-fetoprotein-producing lung carcinoma: report of three cases. Pathol Int. 2002;52(1):46–53. doi:10.1046/j.1440-1827.2002.01311.x
   PubMed Web of Science ®Google Scholar
• Gavrancic T, Park YH. A novel approach using sorafenib in alpha fetoprotein-producing hepatoid adenocarcinoma of the lung. J Natl Compr Canc Netw. 2015;13(4):387–91;quiz 391. doi:10.6004/jnccn.2015.0054
   PubMed Web of Science ®Google Scholar
• Basse V, Schick U, Guéguen P, et al. A mismatch repair-deficient hepatoid adenocarcinoma of the lung responding to anti-PD-L1 durvalumab therapy despite no PD-L1 expression. J Thorac Oncol. 2018;13(7):e120–e122. doi:10.1016/j.jtho.2018.03.004
   PubMed Web of Science ®Google Scholar
• Yoshino I, Hayashi I, Yano T, Takai E, Mizutani K, Ichinose Y. Alpha-fetoprotein-producing adenocarcinoma of the lung. Lung Cancer. 1996;15(1):125–130. doi:10.1016/0169-5002(96)00577-6
   PubMed Web of Science ®Google Scholar
• Carlinfante G, Foschini MP, Pasquinelli G, Scotti R, Cavazza A. Hepatoid carcinoma of the lung: a case report with immunohistochemical, ultrastructural and in-situ hybridization findings. Histopathology. 2000;37(1):88–89. doi:10.1046/j.1365-2559.2000.00955-5.x
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Takanashi Y, Ohsawa H, Ishii H, Nakatani Y. Hepatoid adenocarcinoma in the lung. Lung Cancer. 2002;38(2):211–214. doi:10.1016/s0169-5002(02)00214-3
   PubMed Web of Science ®Google Scholar
• Terracciano LM, Glatz K, Mhawech P, et al. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol. 2003;27(10):1302–1312. doi:10.1097/00000478-200310000-00002
   PubMed Web of Science ®Google Scholar
• Oshiro Y, Takada Y, Enomoto T, Fukao K, Ishikawa S, Iijima T. A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II). Hepatogastroenterology. 2004;51(58):1144–1147.
   PubMedGoogle Scholar
• Wu Z, Upadhyaya M, Zhu H, Qiao Z, Chen K, Miao F. Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases. J Comput Assist Tomogr. 2007;31(6):846–852. doi:10.1097/RCT.0b013e318038f6dd
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Yano T, Hiroshima K, Inayama Y, Kawachi K, Nakatani Y. A case of *-fetoprotein-producing pulmonary carcinoma with restricted expression of hepatocyte nuclear factor-4* in hepatoid foci: a case report with studies of previous cases. Hum Pathol. 2008;39(7):1115–1120. doi:10.1016/j.humpath.2007.12.013
   PubMed Web of Science ®Google Scholar
• Kitada M, Ozawa K, Sato K, et al. Alpha-fetoprotein-producing primary lung carcinoma: a case report. World J Surg Oncol. 2011;9:47. doi:10.1186/1477-7819-9-47
   PubMed Web of Science ®Google Scholar
• Mokrim M, Belbaraka R, Allaoui M, et al. Hepatoid adenocarcinoma of the lung: a case report and literature review. J Gastrointest Cancer. 2012;43(Suppl 1):S125–7. doi:10.1007/s12029-011-9318-5
   PubMedGoogle Scholar
• Khozin S, Roth MJ, Rajan A, et al. Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement. J Thorac Oncol. 2012;7(11):e29–31. doi:10.1097/JTO.0b013e3182697a23
   PubMed Web of Science ®Google Scholar
• Lin SF, Hsu WH, Chou TY. Primary pulmonary hepatoid carcinoma: report of a case and review of the literature. Kaohsiung J Med Sci. 2013;29(9):512–516. doi:10.1016/j.kjms.2013.01.007
   PubMed Web of Science ®Google Scholar
• Cavalcante LB, Felipe-Silva A, de Campos FPF, Martines J. Hepatoid adenocarcinoma of the lung. Autops Case Rep. 2013;3(1):5–14. doi:10.4322/acr.2013.002
   PubMedGoogle Scholar
• Che YQ, Wang S, Luo Y, Wang JB, Wang LH. Hepatoid adenocarcinoma of the lung: presenting mediastinal metastasis without transfer to the liver. Oncol Lett. 2014;8(1):105–110. doi:10.3892/ol.2014.2064
   PubMed Web of Science ®Google Scholar
• Shaib W, Sharma R, Mosunjac M, Farris AB, El Rayes B. Hepatoid adenocarcinoma of the lung: a case report and review of the literature. J Gastrointest Cancer. 2014;45(Suppl 1):99–102. doi:10.1007/s12029-013-9558-7
   PubMedGoogle Scholar
• Sun JN, Zhang BL, Li LK, Yu HY, Wang B. Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: a case report and review of the literature. Oncol Lett. 2016;12(1):189–194. doi:10.3892/ol.2016.4559
   PubMed Web of Science ®Google Scholar
• Qian GQ, Yin FY, Li GX, Chu JG. Hepatoid adenocarcinoma of the lung. Qjm. 2016;109(9):619–620. doi:10.1093/qjmed/hcw107
   PubMed Web of Science ®Google Scholar
• Wang S, Li M, Chen H, Li J, Zeng Q. FDG PET/CT in hepatoid adenocarcinoma of the lung. Clin Nucl Med. 2016;41(7):e340–1. doi:10.1097/rlu.0000000000001231
   PubMed Web of Science ®Google Scholar
• Valle L, Thomas J, Kim C, et al. Hepatoid adenocarcinoma of the lung metastasizing to the tonsil. Mol Clin Oncol. 2017;6(5):705–707. doi:10.3892/mco.2017.1215
   PubMed Web of Science ®Google Scholar
• Ayub A, Nunez Lopez O, Booth A, Okereke I. Pulmonary hepatoid adenocarcinoma. J Thorac Cardiovasc Surg. 2019;158(4):e139–e140. doi:10.1016/j.jtcvs.2019.06.023
   PubMed Web of Science ®Google Scholar
• Kuan K, Khader SN, El Hussein S. Hepatoid adenocarcinoma of the lung. Diagn Cytopathol. 2019;47(8):831–833. doi:10.1002/dc.24195
   PubMed Web of Science ®Google Scholar
• Wang C, Xu G, Wu G, et al. Hepatoid adenocarcinoma of the lung metastasizing to the gingiva. Onco Targets Ther. 2019;12:8765–8768. doi:10.2147/ott.S222974
   PubMed Web of Science ®Google Scholar
• Shi YF, Lu JG, Yang QM, et al. Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: a case report. World J Clin Cases. 2019;7(13):1711–1716. doi:10.12998/wjcc.v7.i13.1711
   PubMed Web of Science ®Google Scholar
• Wang W, Li G. Radiotherapy of pulmonary hepatoid adenocarcinoma with intrahepatic hemangioma: a case report. Onco Targets Ther. 2020;13:11947–11955. doi:10.2147/ott.S275340
   PubMed Web of Science ®Google Scholar
• Muroyama Y, Tamiya H, Tanaka G, et al. Alpha-fetoprotein-producing lung hepatoid adenocarcinoma with brain metastasis treated with S-1. Case Rep Oncol. 2020;13(3):1552–1559. doi:10.1159/000511763
   PubMed Web of Science ®Google Scholar
• Tonyali O, Gonullu O, Ozturk MA, Kosif A, Civi OG. Hepatoid adenocarcinoma of the lung and the review of the literature. J Oncol Pharm Pract. 2020;26(6):1505–1510. doi:10.1177/1078155220903360
   PubMed Web of Science ®Google Scholar
• Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1563–1579. doi:10.1158/1055-9965.Epi-19-0221
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Corlin R, Tompkins R. Serum alpha-fetoglobulin in a patient with hepatic metastasis from brobchogenic carcinoma. Am J Dig Dis. 1972;17:533–535. doi:10.1007/BF02231210
   PubMedGoogle Scholar
• Zhou K, Wang A, Ao S, et al. The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer. 2020;20(1):671. doi:10.1186/s12885-020-07031-9
   PubMed Web of Science ®Google Scholar
• Hou Z, Xie J, Zhang L, Dai G, Chen Y, He L. Hepatoid adenocarcinoma of the lung: a systematic review of the literature from 1981 to 2020. Front Oncol. 2021;11:702216. doi:10.3389/fonc.2021.702216
   PubMed Web of Science ®Google Scholar
• Sun H, Li X, Zhang J, Liu Y. Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: report of four cases. Pathol Res Pract. 2022;229:153652. doi:10.1016/j.prp.2021.153652
   PubMed Web of Science ®Google Scholar
• Yin H, Hu Y, Xiu Y, Luo R, Shi H. A rare case of primary endometrial hepatoid adenocarcinoma on 18F-FDG PET/CT. Clin Nucl Med. 2019;44(7):e425–e427. doi:10.1097/rlu.0000000000002538
   PubMed Web of Science ®Google Scholar
• Deng X, Jin Y, Yang W, et al. An adrenal hepatoid adenocarcinoma with left renal vein thrombosis extending into the inferior vena cava. Urol J. 2019;16(5):511–514. doi:10.22037/uj.v0i0.5250
   PubMed Web of Science ®Google Scholar
• Lin J, Cao Y, Yu L, Lin L. Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: a case report and literature review. Medicine. 2018;97(39):e12336. doi:10.1097/md.0000000000012336
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–d613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60–w64. doi:10.1093/nar/gky311
   PubMed Web of Science ®Google Scholar
• Han H, Cho JW, Lee S, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46(D1):D380–d386. doi:10.1093/nar/gkx1013
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang L, Huang J, et al. Targeted-gene sequencing and bioinformatics analysis of patients with pancreatic mucoepidermoid carcinoma: a case report and literature review. Onco Targets Ther. 2021;14:3567–3581. doi:10.2147/ott.S305248
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–w560. doi:10.1093/nar/gkz430
   PubMed Web of Science ®Google Scholar
• Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Databaseissue):D955–61. doi:10.1093/nar/gks1111
   PubMed Web of Science ®Google Scholar
• Ye L, Mesbah Ardakani N, Thomas C, et al. Detection of low-level EGFR c.2369 C > T (p.Thr790Met) resistance mutation in pre-treatment non-small cell lung carcinomas harboring activating EGFR mutations and correlation with clinical outcomes. Pathol Oncol Res. 2020;26(4):2371–2379. doi:10.1007/s12253-020-00833-z
   PubMed Web of Science ®Google Scholar
• Simone G, Mangia A, Malfettone A, et al. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer. J Exp Clin Cancer Res. 2010;29(1):125. doi:10.1186/1756-9966-29-125
   PubMed Web of Science ®Google Scholar
• Yang Z, Liang SQ, Saliakoura M, et al. Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer. EMBO Mol Med. 2021;e13193. doi:10.15252/emmm.202013193
   PubMed Web of Science ®Google Scholar
• Patsoukis N, Brown J, Petkova V, Liu F, Li L, Boussiotis VA. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci Signal. 2012;5(230):ra46. doi:10.1126/scisignal.2002796
   PubMed Web of Science ®Google Scholar